Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jan. 31, 2020	Jan. 31, 2019
Cash flows from operating activities:
Net income (loss)	$ 78,871	$ 8,536
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	50,586	21,463
Amortization of intangibles	48,566	25,117
Amortization of debt issuance costs	5,371	785
Impairment charges	10,057	0
Foreign currency forward contract loss	0	73,707
Deferred income tax provision (benefit)	1,661	(84)
(Gain) loss on disposition of property, plant and equipment	1,241	(29)
Stock-based compensation expense	10,075	9,486
Changes in assets and liabilities:
Accounts receivable	(121,725)	142,453
Inventories	(109,999)	(23,933)
Prepaid income taxes, expenses and other	5,280	(31,693)
Accounts payable	67,036	(62,208)
Accrued liabilities	(47,216)	(30,213)
Long-term liabilities and other	5,494	1,243
Net cash provided by operating activities	5,298	134,630
Cash flows from investing activities:
Purchases of property, plant and equipment	(52,858)	(54,802)
Proceeds from dispositions of property, plant and equipment	20,350	66
Equity investment in joint venture	0	(3,500)
Other	(4,527)	0
Net cash used in investing activities	(37,035)	(58,236)
Cash flows from financing activities:
Borrowings on revolving asset-based credit facilities	75,007	0
Principal payments on term-loan credit facilities	(155,388)	0
Principal payments on revolving asset-based credit facilities	(47,609)	0
Principal payments on other debt	(7,058)	0
Regular cash dividends paid	(44,159)	(41,189)
Principal payments on finance lease obligations	(214)
Principal payments on capital lease obligations		(203)
Payments related to vesting of stock-based awards	(3,763)	(4,418)
Short-term financial obligations and other, net	9,896	0
Net cash used in financing activities	(173,288)	(45,810)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(566)	0
Net increase (decrease) in cash and cash equivalents and restricted cash	(205,591)	30,584
Cash and cash equivalents and restricted cash, beginning of period	451,262	275,249
Cash and cash equivalents and restricted cash, end of period	245,671	305,833
Less: restricted cash	3,537	0
Cash and cash equivalents, end of period	242,134	305,833
Supplemental cash flow information:
Income taxes paid	46,653	57,728
Interest paid	53,546	1,055
Non-cash investing and financing transactions:
Capital expenditures in accounts payable	$ 2,631	$ 490